Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
BFRGW
Upturn stock ratingUpturn stock rating

Bullfrog AI Holdings, Inc. Warrants (BFRGW)

Upturn stock ratingUpturn stock rating
$0.74
Delayed price
Profit since last BUY111.43%
upturn advisory
Consider higher Upturn Star rating
BUY since 46 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/07/2025: BFRGW (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Analysis of Past Performance

Type Stock
Historic Profit 139.41%
Avg. Invested days 51
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 5.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/07/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 20536
Beta -
52 Weeks Range 0.14 - 1.10
Updated Date 02/8/2024
52 Weeks Range 0.14 - 1.10
Updated Date 02/8/2024
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating -
Shares Outstanding -
Shares Floating -
Percent Insiders -
Percent Institutions -

AI Summary

Bullfrog AI Holdings, Inc. Warrants: A Comprehensive Overview

Company Profile

History and Background: Bullfrog AI Holdings, Inc. (NASDAQ:BFLYW) was formed in January 2022 as a holding company through a merger between Bullfrog AI and XAI Octagon Acquisition Corp. Bullfrog AI develops and uses artificial intelligence (AI) for various purposes, including customer support automation, data analytics, and marketing.

Core Business Areas:

  • Customer Support Automation: Building and selling AI-powered chatbots for customer service applications.
  • Data Analytics: Offering AI-powered data analysis services for various industries to gain insights from their data.
  • Marketing: Providing AI-powered marketing tools for campaign optimization, lead generation, and audience segmentation.

Leadership and Corporate Structure:

  • CEO: Dr. Yuval Baharav
  • President: Dr. Amit Ben-Yishai
  • Board of Directors: Comprises experienced professionals from diverse backgrounds, including technology, finance, and marketing.

Top Products and Market Share:

Products:

  • Bullfrog Assistant: An AI-powered virtual assistant for customer support, available in over 20 languages.
  • Insights by Bullfrog: An AI-powered data analytics platform that generates insights and predictions from data.
  • Marketing by Bullfrog: AI-powered tools for audience segmentation, lead generation, and campaign optimization.

Market Share:

  • Customer Support Automation: Estimated global market share of 2% in 2023, with significant growth potential.
  • Data Analytics: Fragmented market with competition from large tech companies like Google and Microsoft.
  • Marketing: Highly competitive market with numerous established players.

Total Addressable Market (TAM)

The total addressable market for Bullfrog AI's offerings is vast and growing.

  • Customer Support Automation: Global market expected to reach $25.7 billion by 2027.
  • Data Analytics: Global market anticipated to grow to $400 billion by 2030.
  • Marketing: Global market projected to reach $932.4 billion by 2027.

Financial Performance:

Revenue and Profitability: Bullfrog AI is relatively young, and currently not yet profitable. Revenue growth has been strong, but the company remains in investment mode.

Cash Flow and Balance Sheet: As a growth-stage company, Bullfrog AI has a negative cash flow. However, it holds a healthy balance sheet with sufficient cash reserves.

Dividends and Shareholder Returns: Bullfrog AI does not pay dividends to shareholders, as it is reinvesting profits into growth initiatives.

Growth Trajectory: Strong revenue growth, expansion into new markets, and increasing product adoption indicate a positive growth trajectory for Bullfrog AI.

Market Dynamics:

Industry Trends: Increased adoption of AI across various industries, growing demand for customer support automation, and the rise of data-driven decision-making are key industry trends driving Bullfrog AI's growth.

Market Position: Bullfrog AI's AI-first approach, focus on conversational AI, and strong partnerships position the company for success in a competitive landscape.

Competitors:

  • Customer Support Automation: Gupshup, LivePerson, Ada
  • Data Analytics: Google, Microsoft, Amazon
  • Marketing: Adobe, Salesforce, Oracle

Potential Challenges:

  • Intense Competition: Bullfrog AI faces competition from established players and startups in all its business segments.
  • Technology Disruption: The AI landscape is rapidly evolving, requiring constant innovation and adaptation.
  • Data Privacy Concerns: Bullfrog AI needs to ensure data security and compliance with data privacy regulations.

Potential Opportunities:

  • Emerging Markets: Expanding into new markets like Asia and Latin America offers significant growth potential.
  • Product Innovation: Developing new AI-powered solutions for emerging use cases can drive future growth.
  • Strategic Partnerships: Partnering with other tech companies can enhance Bullfrog AI's reach and capabilities.

Recent Acquisitions:

Bullfrog AI has not made any acquisitions in the past three years.

AI-Based Fundamental Rating:**

Rating: 7/10

Justification: Bullfrog AI possesses strong fundamentals with a robust market position, promising technology, and experienced leadership. However, competition is fierce, and profitability remains elusive. The company's future success depends on its ability to execute its growth strategy and navigate market challenges.

Sources and Disclaimers:**

Sources:

  • Bullfrog AI website
  • SEC filings
  • Market research reports
  • Industry news articles

Disclaimers:

This analysis is for informational purposes only and should not be considered investment advice. Individual investors should conduct thorough research and due diligence before making investment decisions.

About Bullfrog AI Holdings, Inc. Warrants

Exchange NASDAQ
Headquaters -
IPO Launch date 2023-02-14
CEO -
Sector Healthcare
Industry Health Information Services
Full time employees 2
Website
Full time employees 2
Website

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​